Cargando…

Cancer Risk and Multiple Sclerosis: Evidence From a Large Italian Cohort

Introduction: The complexity of understanding cancer risk in MS is increased by inconsistencies in study design, and the lack of age-, sex-, and ethnicity-specific risk estimates. Aims of our study were to estimate the incidence of cancers in the MS population of Catania (Italy) and to evaluate the...

Descripción completa

Detalles Bibliográficos
Autores principales:	D'Amico, Emanuele, Chisari, Clara G., Arena, Sebastiano, Zanghì, Aurora, Toscano, Simona, Lo Fermo, Salvatore, Maimone, Davide, Castaing, Marine, Sciacca, Salvatore, Zappia, Mario, Patti, Francesco
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Frontiers Media S.A. 2019
Materias:	Neurology
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6469363/ https://www.ncbi.nlm.nih.gov/pubmed/31024431 http://dx.doi.org/10.3389/fneur.2019.00337

Ejemplares similares

Exploring polypharmacy phenomenon in newly diagnosed relapsing–remitting multiple sclerosis: a cohort ambispective single-centre study
por: Zanghì, Aurora, et al.
Publicado: (2021)

A dynamic interpretation of κFLC index for the diagnosis of multiple sclerosis: a change of perspective
por: Toscano, Simona, et al.
Publicado: (2023)

Immunological Subsets Characterization in Newly Diagnosed Relapsing–Remitting Multiple Sclerosis
por: D’Amico, Emanuele, et al.
Publicado: (2022)

A Personalized Approach in Progressive Multiple Sclerosis: The Current Status of Disease Modifying Therapies (DMTs) and Future Perspectives
por: D’Amico, Emanuele, et al.
Publicado: (2016)

Multiple Sclerosis in the Mount Etna Region: Possible Role of Volcanogenic Trace Elements
por: Nicoletti, Alessandra, et al.
Publicado: (2013)

Reliability of televisits for patients with mild relapsing–remitting multiple sclerosis in the COVID-19 era
por: Toscano, Simona, et al.
Publicado: (2022)

Changes in John Cunningham Virus Index in Multiple Sclerosis Patients Treated with Different Disease-Modifying Therapies
por: Sgarlata, Eleonora, et al.
Publicado: (2022)

Correction to: Reliability of televisits for patients with mild relapsing–remitting multiple sclerosis in the COVID‑19 era
por: Toscano, Simona, et al.
Publicado: (2022)

Toxoplasma gondii and multiple sclerosis: a population-based case–control study
por: Nicoletti, Alessandra, et al.
Publicado: (2020)

First‐line therapies in late‐onset multiple sclerosis: An Italian registry study
por: Zanghì, Aurora, et al.
Publicado: (2021)

Negative prognostic impact of MRI spinal lesions in the early stages of relapsing–remitting multiple sclerosis
por: D’Amico, E, et al.
Publicado: (2016)

Rituximab for the treatment of multiple sclerosis: a review
por: Chisari, Clara Grazia, et al.
Publicado: (2021)

Pregnancy and the Postpartum Period in Women With Relapsing-Remitting Multiple Sclerosis Treated With Old and New Disease-Modifying Treatments: A Real-World Multicenter Experience
por: Zanghì, Aurora, et al.
Publicado: (2020)

Stopping Interferon Beta 1b Does Not Influence the Risk of Disability Accrual in Non-Active SPMS: Results from an Italian Real-World Study
por: Zanghì, Aurora, et al.
Publicado: (2022)

Mental health status of relapsing-remitting multiple sclerosis Italian patients returning to work soon after the easing of lockdown during COVID-19 pandemic: A monocentric experience
por: Zanghì, Aurora, et al.
Publicado: (2020)

Gonadal Steroids and Sperm Quality in a Cohort of Relapsing Remitting Multiple Sclerosis: A Case-Control Study
por: D'Amico, Emanuele, et al.
Publicado: (2020)

Natalizumab administration in multiple sclerosis patients during active SARS-CoV-2 infection: a case series
por: Chisari, Clara G., et al.
Publicado: (2021)

Early-Onset Alcohol Dependence and Multiple Sclerosis: Diagnostic Challenges
por: Luca, Maria, et al.
Publicado: (2021)

Autologous Hematopoietic Stem Cell Transplantation in Multiple Sclerosis Patients: Monocentric Case Series and Systematic Review of the Literature
por: Patti, Francesco, et al.
Publicado: (2022)

Comparable efficacy and safety of dimethyl fumarate and teriflunomide treatment in Relapsing-Remitting Multiple Sclerosis: an Italian real-word multicenter experience
por: D’Amico, Emanuele, et al.
Publicado: (2018)

Multiple Sclerosis and CCSVI: A Population-Based Case Control Study
por: Patti, Francesco, et al.
Publicado: (2012)

Multiple Sclerosis, COVID-19 and Vaccines: Making the Point
por: Toscano, Simona, et al.
Publicado: (2021)

Lights and Shadows of Cyclophosphamide in the Treatment of Multiple Sclerosis
por: Patti, Francesco, et al.
Publicado: (2011)

Injectable versus oral first-line multiple sclerosis therapies: knows and unknowns from observational studies
por: D'Amico, Emanuele, et al.
Publicado: (2021)

The Neutrophil-to-Lymphocyte Ratio is Related to Disease Activity in Relapsing Remitting Multiple Sclerosis
por: D’Amico, Emanuele, et al.
Publicado: (2019)

Editorial: Immunosenescence and multiple sclerosis: Prognostic and therapeutic implications
por: Zanghì, Aurora, et al.
Publicado: (2022)

Ofatumumab and Early Immunological Cells Subset Characterization in Naïve Relapsing Multiple Sclerosis Patients: A Real-World Study
por: D’Amico, Emanuele, et al.
Publicado: (2023)

MiRNA 106a-5p in cerebrospinal fluid as signature of early relapsing remitting multiple sclerosis: a cross sectional study
por: Zanghì, Aurora, et al.
Publicado: (2023)

Prevalence and predictors of bowel dysfunction in a large multiple sclerosis outpatient population: an Italian multicenter study
por: Alvino, Bisecco, et al.
Publicado: (2021)

Correction to: Prevalence and predictors of bowel dysfunction in a large multiple sclerosis outpatient population: an Italian multicenter study
por: Bisecco, Alvino, et al.
Publicado: (2022)

Metabolic Abnormalities, Dietary Risk Factors and Nutritional Management in Amyotrophic Lateral Sclerosis
por: D’Amico, Emanuele, et al.
Publicado: (2021)

Is It Time for Ocrelizumab Extended Interval Dosing in Relapsing Remitting MS? Evidence from An Italian Multicenter Experience During the COVID-19 Pandemic
por: Zanghì, Aurora, et al.
Publicado: (2022)

Offspring Number Does Not Influence Reaching the Disability’s Milestones in Multiple Sclerosis: A Seven-Year Follow-Up Study
por: D’Amico, Emanuele, et al.
Publicado: (2016)

Effectiveness of Ocrelizumab in Primary Progressive Multiple Sclerosis: a Multicenter, Retrospective, Real-world Study (OPPORTUNITY)
por: Chisari, Clara G., et al.
Publicado: (2023)

Personality Traits and Fatigue in Multiple Sclerosis: A Narrative Review
por: Ciancio, Alessia, et al.
Publicado: (2023)

Heavy Metals Concentrations in Fish from Sicily (Mediterranean Sea) and Evaluation of Possible Health Risks to Consumers
por: Copat, Chiara, et al.
Publicado: (2011)

The role of weight status, gender and self-esteem in following a diet among middle-school children in Sicily (Italy)
por: Ferrante, Margherita, et al.
Publicado: (2010)

PACAP Modulates the Autophagy Process in an In Vitro Model of Amyotrophic Lateral Sclerosis
por: D’Amico, Agata Grazia, et al.
Publicado: (2020)

Injectable Versus Oral First-Line Disease-Modifying Therapies: Results from the Italian MS Register
por: D’Amico, Emanuele, et al.
Publicado: (2021)

Pesticide exposure assessed through agricultural crop proximity and risk of amyotrophic lateral sclerosis
por: Vinceti, Marco, et al.
Publicado: (2017)

Cannot write session to /tmp/vufind_sessions/sess_fpito6r0pd5hq353dg6pg8qm6b